Navigation Links
What makes a plant a plant?
Date:6/15/2011

Palo Alto, CA Although scientists have been able to sequence the genomes of many organisms, they still lack a context for associating the proteins encoded in genes with specific biological processes. To better understand the genetics underlying plant physiology and ecologyespecially in regard to photosynthesisa team of researchers including Carnegie's Arthur Grossman identified a list of proteins encoded in the genomes of plants and green algae, but not in the genomes of organisms that don't generate energy through photosynthesis. Their work will be published June 17 in the Journal of Biological Chemistry.

Using advanced computational tools to analyze the genomes of 28 different plants and photosynthetic organisms, Grossman and his colleagues at the University of California in Los Angeles and the Joint Genome Institute of the Department of Energy were able to identify 597 proteins encoded on plant and green algal genomes, but that are not present in non-photosynthetic organisms. They call this suite of proteins the GreenCut.

Interestingly, of the 597 GreenCut proteins, 286 have known functions, while the remaining 311 have not been associated with a specific biological process and are called "unknowns."

The majority of the GreenCut proteins, 52 percent, have been localized in a cellular organelle called the chloroplast--the compartment where photosynthesis takes place. It is widely accepted that chloroplasts originated from photosynthetic, single-celled bacteria called cyanobacteria, which were engulfed by a more complex, non-photosynthetic cell more than 1.5 billion years ago. While the relationship between the two organisms was originally symbiotic, over evolutionary time the cyanobacterium transferred most of its genetic information to the nucleus of the host organism, losing its ability to live independent of its partner.

"This genetically-reduced cyanobacterium, which is now termed a chloroplast, has maintained
'/>"/>

Contact: Arthur Grossman
arthurg@stanford.edu
650-325-1521 x212
Carnegie Institution
Source:Eurekalert

Page: 1 2

Related biology news :

1. Columbia Engineering team makes major step in improving forecasts of weather extremes
2. Small change makes a big difference for ion channels
3. Fish species discovered by LSU researcher makes 2011 top 10 list
4. What doesnt kill the brain makes it stronger
5. Missouri Botanical Garden makes rare discovery of plant genus
6. Laser beam makes cells breathe in water and potentially anti-cancer drugs
7. University of Missouri researcher study provides insight into how corn makes hormones
8. Algal antifreeze makes inroads into ice
9. HIV makes protein that may help viruss resurgence
10. Nanowire research at Stevens makes cover of Applied Physics Letters
11. UMASS Medical Schools human stem cell bank makes available first seven stem cell lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... have engineered a strain of electricity-producing bacteria that can ... and carbon dioxide as its sole source of carbon. ... their findings at the 113th General Meeting of the ... result of current production solely on hydrogen," says Amit ... his co-authors are part of the Lovley Lab Group ...
(Date:5/18/2013)... presented today at Digestive Disease Week (DDW) explores new ... impact of coffee on autoimmune disease and palliative care ... has been associated with reduced risk of fibrosis, a ... of java each month also correlate with lower risk ... Mayo Clinic, Rochester, MN, linked coffee consumption with reduced ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
... a mile below the ocean surface donot bother ... to one spot. Fornourishment, they rely completely onsymbiotic ... sulphurous volcanicsoup in which they both thrive. , ... bacteria-free, with a completedigestive system. Juveniles swim, hunt, ...
... in some animals to periodically wake up while hibernating may ... researchers at Penn State. The finding could offer an insight ... and has potential implications for human health. , ... part of a unique strategy to get past harsh winters ...
... It may be possible to protect the testes of cancer ... scientist told the 22nd annual conference of the European Society ... Tuesday 20 June 2006. Mr. Alon Carmely from ... for the first time that the injection of a drug ...
Cached Biology News:Giant deep-sea tubeworm's meal ticket comes in as a skin infection 2Giant deep-sea tubeworm's meal ticket comes in as a skin infection 3Breaks in hibernation help fight bugs 2Injection may prevent infertility in men receiving cancer chemotherapy 2
(Date:5/20/2013)... May 20, 2013 Kitware, a leader ... tool that enables the exploration of hospital costs ... in response to the recent release of “Medicare Provider ... top 100 most-billed procedures from the Centers for Medicare ... for similar procedures at hospitals across the country has ...
(Date:5/17/2013)... May 17, 2013 Topricin Pain ... Inc., has been listed among nationally recommended over-the-counter ... initiative conducted by "U.S. News" Health in collaboration ... the “No. 1 Pharmacists Recommended designation” in ... national OTC brands, and is the only homeopathic ...
(Date:5/17/2013)... world-leading provider of scientific, technical and medical information products ... study in Reproductive BioMedicine Online ... an abnormal chromosomal composition can be identified by the ... classifying the risk of genetic abnormality without a biopsy. ... a retrospective study, using their predictive model to assess ...
(Date:5/17/2013)... , May 17, 2013  Yongye International, Inc. (NASDAQ: ... leading developer, manufacturer, and distributor of crop nutrient products ... , today announced that, on May 16, 2013, the ... directors (the "Board of Directors") was provided a letter ... Hong Kong ) Limited ("Abax") to Full Alliance ...
Breaking Biology Technology:Kitware Enables Interactive Exploration of CMS Medicare Data 2Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Breakthrough for IVF? 2Breakthrough for IVF? 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4
... 5 , - Data Presented ... York , ThromboGenics NV (Euronext Brussels: ... innovative medicines for eye,disease, vascular disease and cancer, today announces ... the treatment of,Diabetic Macular Edema (MIVI II DME). The data ...
... , LA JOLLA, Calif., Oct. 5 Transdel Pharmaceuticals, Inc. ... a conference call and audio webcast on Tuesday, October 6, ... of its Phase 3 clinical study for Ketotransdel®, a topical ... A press release will be issued on Tuesday, October 6, ...
... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported ... bavituximab in combination with carboplatin and paclitaxel in patients ... reported from the initial cohort of 21 patients in ... patients with locally advanced or metastatic NSCLC achieved an ...
Cached Biology Technology:ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME) 2ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME) 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME) 4Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday, October 6, 2009 to Announce Top-Line Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R) 2Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday, October 6, 2009 to Announce Top-Line Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R) 3Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 3Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 4
PEG 8000 is used in the precipitation of phage, isolation of plasmid DNA and the enhancement of blunt-ended ligation reactions....
Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers...
... all types of yeast two-hybrid studies, including complex interaction ... Choice of two bait vectors for maximum flexibility ... Triple reporter strain NMY51 ensures ... Complete set of controls: pLexA-p53, pLexA-lamin C ...
PlusOne EDTA, disodium salt, 100 g. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Buffers....
Biology Products: